The SEC Division of Corporation Finance published CF Disclosure Guidance: Topic No. 7 to address how and what to submit when filing an application objecting to public release of information otherwise required to be filed under the Securities Act and the Securities Exchange Act. The guidance replaces and supersedes the guidance provided in Staff Legal Bulletins 1 and 1A.
This guidance has been generally updated, including with respect to options for confidential treatment orders that are about to expire. Different extension procedures apply depending on whether the order is greater or less than three years old. The prior version of this guidance referred to a fixed date rather than a rolling three-year period.
Click here to view CF Disclosure Guidance: Topic No. 7 on the SEC’s website.